ASP Isotopes is developing a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. The Company’s proprietary technologies, the Aerodynamic Separation Process (“ASP technology”) and Quantum Enrichment (“QE technology”), are designed to enable the production of isotopes for a range of industrial and advanced technology applications. ASP Isotopes operates isotope enrichment facilities in Pretoria, South Africa, focused on the enrichment of low atomic mass elements, or light isotopes.
| Website | https://aspisotopes.com/ |
| Employees | 151 (97 on RocketReach) |
| Phone | +1 858-677-1400 |
| Industry | Chemical Manufacturing |
| Keywords | Isotope Separation, Isotope Enrichment, Advanced Materials, Materials Science, Isotope Production, Isotope Technology, Isotope Research, Separation Processes, Stable Isotopes, Radioisotopes, Isotope Applications, Isotopic Analysis, Isotope Services, Scientific Instruments, Nuclear Technology, Scientific Research |
| Competitors | Thermo Fisher Scientific, Siemens Healthineers, Bayer, GE, Lantheus, Bracco, Radiopharm Theranostics, Actinium Pharmaceuticals, Inc., Nordion, IdaTech , LLC +34 more (view full list) |
Looking for a particular ASP Isotopes employee's phone or email?
Paul Mann is the Founder and Executive Chairman (and CEO Sept 2021 - Oct 2025) of ASP Isotopes.
97 people are employed at ASP Isotopes.
ASP Isotopes is based in Dallas, Texas.